Pancreatic cancer: the role of cholecystokinin?

scientific article published on December 1, 1992

Pancreatic cancer: the role of cholecystokinin? is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.3109/00365529209028128
P698PubMed publication ID1475628

P2093author name stringHåkanson R
I. Ihse
R. Håkanson
J. Axelson
P2860cites workDistinct cholecystokinin receptors in brain and pancreasQ28366068
Hormonal control of gastric and colorectal cancer in manQ34531654
Longterm pancreaticobiliary diversion stimulates hyperplastic and adenomatous nodules in the rat pancreas: a new model for spontaneous tumour formationQ34533151
Gastrin receptors on isolated canine parietal cellsQ34610134
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokininQ35615472
Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonistQ35615494
Neuropeptide growth factors and cancerQ37664018
Cholecystokinin and gastrointestinal cancerQ38031478
Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptideQ38342425
The achlorhydria-carcinoid sequence: role of gastrinQ39518375
Trypsin as a Regulator of Pancreatic Secretion in the RatQ39588733
Role of gastrin and cholecystokinin in tumours of the gastrointestinal tractQ39635742
Interface between adaptive and neoplastic growth in the pancreasQ39685995
Feedback regulation of pancreatic enzyme secretion by intestinal trypsin in manQ41053111
Endogenous cholecystokinin regulates growth of human cholangiocarcinomaQ41225133
Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation testsQ41228727
Effect of secretin and cholecystokinin-pancreozymin on plasma CEA concentration in patients with pancreatic carcinoma and pancreatitisQ41673002
Effects of a high-fat diet and L364,718 on growth of human pancreas cancerQ41731843
Effect of pancreatic atrophy and hypertrophy on the small intestineQ42088040
Establishment of a cholecystokinin-producing rat medullary thyroid carcinoma cell lineQ42122905
Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine modelQ42374570
Pancreatic secretory abnormalities precede appearance of tumors of the pancreas in hamsters treated with bis-(2-oxopropyl)-N-nitrosamineQ42453063
Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.Q43183791
Increased incidence of pancreatic neoplasia in pernicious anemiaQ43721752
Cholecystokinin is responsible for growth of the pancreas after pancreaticobiliary diversion in ratsQ44851659
Neuropeptides in neurological tumoursQ48587993
Expression of cholecystokinin forms by medullary thyroid cancer.Q51610098
Saturation of fat and cholecystokinin release: implications for pancreatic carcinogenesis.Q53512872
Trophic effects of cholecystokinin octapeptide on the pancreas of the Syrian hamster.Q53566347
Effect of a soybean diet on enzyme content and ultrastructure of the rat exocrine pancreas.Q54191132
Isolation and structure of caerulein, an active decapeptide from the skin ofHyla caeruleaQ57487511
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectpancreatic cancerQ212961
cholecystokininQ60315441
P304page(s)993-998
P577publication date1992-12-01
P1433published inScandinavian Journal of GastroenterologyQ7429960
P1476titlePancreatic cancer: the role of cholecystokinin?
P478volume27

Reverse relations

cites work (P2860)
Q30881613Closing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma
Q50172615Gallstones, a cholecystectomy, chronic pancreatitis, and the risk of subsequent pancreatic cancer in diabetic patients: a population-based cohort study
Q52542903Genetic analysis of pancreatic duct hyperplasia in Otsuka Long-Evans Tokushima Fatty rats: possible association with a region on rat chromosome 14 that includes the disrupted cholecystokinin-A receptor gene.
Q38055281Metabolic syndrome components and risk factors for pancreatic adenocarcinoma: a case-control study in China
Q40452708On the role of cholecystokinin in pancreatic cancer.
Q35365557Risk of pancreatic cancer after cholecystectomy: a cohort study in Sweden
Q28260872Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors
Q77750274The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas

Search more.